Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Candida auris, a multidrug-resistant yeast that causes invasive infections, was first described in 2009 in Japan and has since been reported from several countries. METHODS: To understand the global emergence and epidemiology of C. auris, we obtained isolates from 54 patients with C. auris infection from Pakistan, India, South Africa, and Venezuela during 2012-2015 and the type specimen from Japan. Patient information was available for 41 of the isolates. We conducted antifungal susceptibility testing and whole-genome sequencing (WGS). RESULTS: Available clinical information revealed that 41% of patients had diabetes mellitus, 51% had undergone recent surgery, 73% had a central venous catheter, and 41% were receiving systemic antifungal therapy when C. auris was isolated. The median time from admission to infection was 19 days (interquartile range, 9-36 days), 61% of patients had bloodstream infection, and 59% died. Using stringent break points, 93% of isolates were resistant to fluconazole, 35% to amphotericin B, and 7% to echinocandins; 41% were resistant to 2 antifungal classes and 4% were resistant to 3 classes. WGS demonstrated that isolates were grouped into unique clades by geographic region. Clades were separated by thousands of single-nucleotide polymorphisms, but within each clade isolates were clonal. Different mutations in ERG11 were associated with azole resistance in each geographic clade. CONCLUSIONS: C. auris is an emerging healthcare-associated pathogen associated with high mortality. Treatment options are limited, due to antifungal resistance. WGS analysis suggests nearly simultaneous, and recent, independent emergence of different clonal populations on 3 continents. Risk factors and transmission mechanisms need to be elucidated to guide control measures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“C. auris, a novel Candida species first identified in 2009, has emerged since 2013 as a cause of nosocomial outbreaks in multiple countries across 5 continents.”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [16]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Resistance to all three classes of antifungals is reported most commonly in India in South Asia (3%), whereas this is much less common in other regions of the world.122–124”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [122]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Invasive C. auris infections are associated with high mortality rates, with 60% of hospitalizations due to C. auris infections resulting in death (8).”
From Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris : Results from a Phase 2 Trial (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Three such mutations, encoding the amino acid substitutions VF125AL (commonly referred to as F126L), Y132F, and K143R, are frequently reported among fluconazole-resistant clinical isolates, and associations between these mutations and specific genetic clades of C. auris have been observed (2).”
From Mutations in TAC1B : a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris (2020) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, up to 96% of C. auris may exhibit resistance to fluconazole, an exceptionally high value compared to 0.5–2% for C. albicans, 4–9% for C. tropicalis, 2–6% for C. parapsilosis, and 11–13% for C. glabrata [16,40,41].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [16]
Experimental — accuracy not yet measured
29 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
Tamura, K., Stecher, G., Peterson, D., Filipski, A., & Kumar, S. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst197 · Cited by 47,205
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895 · cited 1×
“SNPs were identified using 2 independent pipelines, as described elsewhere (see also the legend to Supplemental Figure 1) [15, 19].”
MethodEpidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 2×
“auris because we did not have a comparison group of patients with other Candida infections from the same institutions [31].”
BackgroundResultNonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data
Chin, C.-S., Alexander, D. H., Marks, P., Klammer, A. A., Drake, J., Heiner, C., Clum, A., Copeland, A., Huddleston, J., Eichler, E. E., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2474 · Cited by 4,029 · cited 1×
“The reference genome was generated by de novo assembly of PacBio reads from isolate B8441, as described elsewhere [18], and used as a reference for single-nucleotide polymorphism (SNP) calling.”
MethodSatoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K., & Yamaguchi, H. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00083.x · Cited by 1,381 · cited 8×
“To understand the global emergence and epidemiology of C. auris, we obtained isolates from 54 patients with C. auris infection from Pakistan, India, South Africa, and Venezuela during 2012–2015 and the type specimen from Japan.”
BackgroundInfluentialEvolution of pathogenicity and sexual reproduction in eight Candida genomes
Butler, G., Rasmussen, M. D., Lin, M. F., Santos, M. A. S., Sakthikumar, S., Munro, C. A., Rheinbay, E., Grabherr, M., Forche, A., Reedy, J. L., et al. (2009) · Nature · doi:10.1038/nature08064 · Cited by 1,065 · cited 1×
“5 Mb, similar to that of other Candida species [25].”
BackgroundSelf-citationKathuria, S., Singh, P. K., Sharma, C., Prakash, A., Masih, A., Kumar, A., Meis, J. F., & Chowdhary, A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00367-15 · Cited by 532 · cited 1×
“It phenotypically resembles Candida haemulonii and requires use of molecular methods for identification [9, 10].”
MethodSelf-citationFirst Three Reported Cases of Nosocomial Fungemia Caused by Candida auris
Lee, W. G., Shin, J. H., Uh, Y., Kang, M. G., Kim, S. H., Park, K. H., & Jang, H.-C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00319-11 · Cited by 523 · cited 2×
“auris [3], establishing that this new species was capable of causing invasive infections.”
BackgroundPerea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470
Incidence, characteristics and outcome of ICU-acquired candidemia in India
Chakrabarti, A., Sood, P., Rudramurthy, S. M., Chen, S., Kaur, H., Capoor, M., Chhina, D., Rao, R., Eshwara, V. K., Xess, I., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-014-3603-2 · Cited by 454 · cited 1×
“auris may become widely established within certain regions, as evidenced by the fact that it now accounts for nearly 5% of candidemia in Indian intensive care units [5].”
Background
Cited by
Items 201–300 of 1,007
Ruiz-Gaitán, A., Martínez, H., Moret, A. M., Calabuig, E., Tasias, M., Alastruey-Izquierdo, A., Zaragoza, Ó., Mollar, J., Frasquet, J., Salavert-Lletí, M., et al. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1592675 · Cited by 92
“Low MICs of Itraconazole, isavuconazole, and posaconazole were found in our isolates in agreement with previous studies [15,30,37], but isolates with elevated MICs have also been reported.”
BackgroundResultEmerging Fungal Infections: New Species, New Names, and Antifungal Resistance
Wiederhold, N. P. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvab217 · Cited by 111
“By whole genome sequencing, each clade differs by >10 000 single nucleotide polymorphisms (SNPs), while far fewer SNPs (range <16 to >70) were identified within each clade (7).”
BackgroundVazquez, J. A., Pappas, P. G., Boffard, K., Paruk, F., Bien, P. A., Tawadrous, M., Ople, E., Wedel, P., Oborska, I., & Hodges, M. R. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01419-22 · Cited by 92
“auris infections resulting in death (8).”
Donor-Derived Transmission of Candida auris During Lung Transplantation
Azar, M. M., Turbett, S. E., Fishman, J. A., & Pierce, V. M. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix460 · Cited by 89
Candida auris for the Clinical Microbiology Laboratory: Not Your Grandfather's Candida Species
Lockhart, S. R., Berkow, E. L., Chow, N., & Welsh, R. M. (2017) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2017.06.003 · Cited by 93
“auris isolates from Japan, India, Pakistan, South Africa, and Venezuela were sequenced and the results were startling [9].”
InfluentialSelf-citationCandida auris on Apples: Diversity and Clinical Significance
Yadav, A., Jain, K., Wang, Y., Pawar, K., Kaur, H., Sharma, K. K., Tripathy, V., Singh, A., Xu, J., & Chowdhary, A. (2022) · mBio · doi:10.1128/mbio.00518-22 · Cited by 86
Self-citationBorman, A. M., Fraser, M., & Johnson, E. M. (2021) · Medical Mycology · doi:10.1093/mmy/myaa049 · Cited by 88
Eldesouky, H. E., Li, X., Abutaleb, N. S., Mohammad, H., & Seleem, M. N. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.08.016 · Cited by 90
Wall, G., Chaturvedi, A. K., Wormley, F. L., Wiederhold, N. P., Patterson, H. P., Patterson, T. F., & Lopez-Ribot, J. L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01084-18 · Cited by 88
“In a recent retrospective review of the clinical history of 54 patients, most had multiple risk factors for invasive disease, and candidemia was observed in 61% (8).”
BackgroundWasi, M., Khandelwal, N. K., Moorhouse, A. J., Nair, R., Vishwakarma, P., Bravo Ruiz, G., Ross, Z. K., Lorenz, A., Rudramurthy, S. M., Chakrabarti, A., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01445 · Cited by 89
Choi, Y. J., Kim, Y.-J., Yong, D., Byun, J.-H., Kim, T. S., Chang, Y. S., Choi, M. J., Byeon, S. A., Won, E. J., Kim, S. H., et al. (2018) · Emerging Infectious Diseases · doi:10.3201/eid2409.180625 · Cited by 88
“auris isolates from Pakistan (10/16 isolates), India (12/17 isolates), and Venezuela (5/5 isolates); these isolates are strongly associated with clonal transmission (9).”
BackgroundCandida auris: Epidemiology and Antifungal Strategy
Eix, E. F., & Nett, J. E. (2025) · Annual Review of Medicine · doi:10.1146/annurev-med-061523-021233 · Cited by 74
de Groot, T., Puts, Y., Berrio, I., Chowdhary, A., & Meis, J. F. (2020) · mBio · doi:10.1128/mbio.02971-19 · Cited by 88
“In the present study, we typed 25 isolates, obtained from India, Pakistan, South Africa, and Venezuela by STR which were previously analyzed using WGS (see Fig.”
MethodResultInfluentialSelf-citationCandida auris: A Decade of Understanding of an Enigmatic Pathogenic Yeast
Kean, R., Brown, J., Gulmez, D., Ware, A., & Ramage, G. (2020) · Journal of Fungi · doi:10.3390/jof6010030 · Cited by 86
Fu, C., Zhang, X., Veri, A. O., Iyer, K. R., Lash, E., Xue, A., Yan, H., Revie, N. M., Wong, C., Lin, Z.-Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26850-3 · Cited by 83
Strategies to Prevent Transmission of Candida auris in Healthcare Settings
Ahmad, S., & Asadzadeh, M. (2023) · Current Fungal Infection Reports · doi:10.1007/s12281-023-00451-7 · Cited by 77
Keighley, C., Garnham, K., Harch, S. A. J., Robertson, M., Chaw, K., Teng, J. C., & Chen, S. C.-A. (2021) · Current Fungal Infection Reports · doi:10.1007/s12281-021-00420-y · Cited by 87
The first cases of Candida auris candidaemia in Oman
Mohsin, J., Hagen, F., Al‐Balushi, Z. A. M., de Hoog, G. S., Chowdhary, A., Meis, J. F., & Al‐Hatmi, A. M. S. (2017) · Mycoses · doi:10.1111/myc.12647 · Cited by 83
Self-citationFrom Ocean to Medicine: Pharmaceutical Applications of Metabolites from Marine Bacteria
dos Santos, J. D. N., Vitorino, I. R., Reyes, F., Vicente, F., & Lage, O. M. (2020) · Antibiotics · doi:10.3390/antibiotics9080455 · Cited by 94
“Moreover, the CDC also reports that about 90% of Candida auris isolates are resistant to fluconazole and 33% to amphotericin B [7].”
BackgroundShort, B., Brown, J., Delaney, C., Sherry, L., Williams, C., Ramage, G., & Kean, R. (2019) · Journal of Hospital Infection · doi:10.1016/j.jhin.2019.06.006 · Cited by 87
Bing, J., Hu, T., Zheng, Q., Muñoz, J. F., Cuomo, C. A., & Huang, G. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01466-20 · Cited by 86
“The lanosterol 14-alpha-demethylase Erg11 is a key enzyme of the ergosterol Citation Bing J, Hu T, Zheng Q, Muñoz JF, Cuomo CA, Huang G. 2021.”
BackgroundInfluentialSelf-citationPreventing Transmission of Multidrug-Resistant Pathogens in the Intensive Care Unit
Strich, J. R., & Palmore, T. N. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.05.010 · Cited by 95
Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis
Murphy, S. E., & Bicanic, T. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.759408 · Cited by 83
Probiotic Yeasts Inhibit Virulence of Non -albicans Candida Species
Kunyeit, L., Kurrey, N. K., Anu‐Appaiah, K. A., & Rao, R. P. (2019) · mBio · doi:10.1128/mbio.02307-19 · Cited by 89
Adler‐Moore, J., Lewis, R. E., Brüggemann, R. J. M., Rijnders, B. J. A., Groll, A. H., & Walsh, T. J. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz064 · Cited by 90
Martini, C., Torelli, R., de Groot, T., De Carolis, E., Morandotti, G. A., De Angelis, G., Posteraro, B., Meis, J. F., & Sanguinetti, M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00232 · Cited by 82
“…several countries (de Groot et al., 2020), it is noteworthy that the Erg11p Y132F substitution has also been reported in C. auris isolates from India, Pakistan, and Venezuela, and that these isolates are strongly associated with clonal transmission (Lockhart et al., 2017; Chowdhary et al., 2018).”
BackgroundSelf-citationWhat do we know about the biology of the emerging fungal pathogen of humans Candida auris?
Bravo Ruiz, G., & Lorenz, A. (2021) · Microbiological Research · doi:10.1016/j.micres.2020.126621 · Cited by 85
Candida auris: A Quick Review on Identification, Current Treatments, and Challenges
Černáková, L., Roudbary, M., Brás, S., Tafaj, S., & Rodrigues, C. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094470 · Cited by 91
“The clades are, thus, from South Asian, East Asian, African, and South American (I to IV, respectively) [8,9].”
BackgroundRosam, K., Monk, B. C., & Lackner, M. (2020) · Journal of Fungi · doi:10.3390/jof7010001 · Cited by 95
“Strains of the South Asian clade carry most frequently the Y132F and/or K143R substitutions, especially clinical isolates from India and Pakistan [94,95].”
BackgroundCandida parapsilosis complex in the clinical setting
Govrins, M. A., & Lass‐Flörl, C. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00961-8 · Cited by 94
Rogers, T. R., Verweij, P. E., Castanheira, M., Dannaoui, E., White, P. L., Arendrup, M. C., Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST), Arendrup, M. C., Arikan-Akdagli, S., Barchiesi, F., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac161 · Cited by 82
Self-citationBurrack, L. S., Todd, R. T., Soisangwan, N., Wiederhold, N. P., & Selmecki, A. (2022) · mBio · doi:10.1128/mbio.00842-22 · Cited by 82
“SNVs in ERG11, the target of fluconazole, and TAC1B, a regulator of drug 258 export pumps, correlate with azole resistance in published datasets [4,11,16,44].”
BackgroundMethodInfluentialNovel ERG11 and TAC1b Mutations Associated with Azole Resistance in Candida auris
Li, J., Coste, A. T., Liechti, M., Bachmann, D., Sanglard, D., & Lamoth, F. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02663-20 · Cited by 82
“(azoles, polyenes, and echinocandins) (1).”
BackgroundInfluentialWiederhold, N. P., Lockhart, S. R., Najvar, L. K., Berkow, E. L., Jaramillo, R., Olivo, M., Garvey, E. P., Yates, C. M., Schotzinger, R. J., Catano, G., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02233-18 · Cited by 79
“Candida auris is an emergingin pathogen that has become a significant clinical problem and has now been isolated in numerous countries worldwide (1, 2).”
BackgroundSelf-citationAhmad, S., Khan, Z., Al‐Sweih, N., Alfouzan, W., & Joseph, L. (2020) · Mycoses · doi:10.1111/myc.13022 · Cited by 79
León‐Buitimea, A., Garza-Cervantes, J. A., Gallegos-Alvarado, D. Y., Osorio-Concepción, M., & Morones‐Ramírez, J. R. (2021) · Pathogens · doi:10.3390/pathogens10101303 · Cited by 93
“auris isolates are resistant to fluconazole, amphotericin B, and echinocandins; probably, this phenomenon is the result of the uncontrolled and prolonged use of existing use antifungals [56,57].”
BackgroundAntifungal Susceptibility Testing: A Primer for Clinicians
Wiederhold, N. P. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab444 · Cited by 88
“rently available antifungals has also been described in some isolates [7, 9, 10].”
BackgroundEnvironmental reservoirs of the drug-resistant pathogenic yeast Candida auris
Akinbobola, A., Kean, R., Hanifi, S. M. A., & Quilliam, R. S. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011268 · Cited by 88
“Environment Soil Acquisition of virulence attributes through survival in harsh soil conditions Adaptation to fungicide in soil Adaptation to higher temperature in soil niches due to global warming Reported isolation of closely related species [25,70,78] Marine ecosystem Halotolerant ability of C. auris Reported isolat…”
BackgroundInfluentialAngeles, L. F., Islam, S., Aldstadt, J., Saqeeb, K. N., Alam, M., Khan, M. A., Johura, F.-T., Ahmed, S. I., & Aga, D. S. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2019.136285 · Cited by 80
Antifungal Resistance: An Emerging Reality and A Global Challenge
Kontoyiannis, D. P. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix179 · Cited by 76
“Reports of non-Candida species resistant to azoles and of multidrug-resistant Candida species, such as Candida glabrata [12] or, lately, Candida auris [13], are increasing with alarming frequency.”
BackgroundLepak, A. J., Zhao, M., & Andes, D. R. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01572-18 · Cited by 79
Horton, M. V., Johnson, C. J., Zarnowski, R., Andes, B. D., Schoen, T. J., Kernien, J. F., Lowman, D., Kruppa, M. D., Ma, Z., Williams, D. L., et al. (2021) · mSphere · doi:10.1128/msphere.00406-21 · Cited by 79
“To determine if evasion of neutrophil response is a conserved trait across a variety of C. auris strains, we measured neutrophil phagocytosis for a panel of ten C. auris isolates collected by the Centers for Disease Control and Prevention (6).”
BackgroundMethodInfluentialThe evolving species concepts used for yeasts: from phenotypes and genomes to speciation networks
Boekhout, T., Aime, M. C., Begerow, D., Gabaldón, T., Heitman, J., Kemler, M., Khayhan, K., Lachance, M., Louis, E. J., Sun, S., et al. (2021) · Fungal Diversity · doi:10.1007/s13225-021-00475-9 · Cited by 85
In Vitro Antifungal Resistance of Candida auris Isolates from Bloodstream Infections, South Africa
Maphanga, T. G., Naicker, S. D., Kwenda, S., Muñoz, J. F., van Schalkwyk, E., Wadula, J., Nana, T., Ismail, A., Coetzee, J., Govind, C., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00517-21 · Cited by 78
“Resistant (n= 84) Fluconazole 1 (8) 60 (78) 1 (50) Amphotericin B 0 1 (1) 0 Micafungin 0 0 0 Fluconazole and amphotericin B 12 (92) 7 (9) 0 Fluconazole, amphotericin B, and micafungin 0 2 (3) 0”
BackgroundResultInfluentialSelf-citationFarmakiotis, D., & Kontoyiannis, D. P. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.05.019 · Cited by 83
Ball, B., Langille, M. G. I., & Geddes‐McAlister, J. (2020) · mBio · doi:10.1128/mbio.01020-20 · Cited by 84
“auris simultaneous emergence on three different continents may be the first representation of the consequences of rising global temperatures (22, 23).”
BackgroundMolecular Epidemiology of Candida Auris Outbreak in a Major Secondary-Care Hospital in Kuwait
Alfouzan, W., Ahmad, S., Dhar, R., Asadzadeh, M., Almerdasi, N., Abdo, N. M., Joseph, L., de Groot, T., Alali, W. Q., Khan, Z., et al. (2020) · Journal of Fungi · doi:10.3390/jof6040307 · Cited by 74
Self-citationCandida auris: a worrisome, globally emerging pathogen
Navalkele, B. D., Revankar, S., & Chandrasekar, P. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1364992 · Cited by 74
“Falsely elevated MICs of amphotericin B and caspofungin were reported by Vitek 2 and CLSI-BMD, respectively [5,32].”
BackgroundInfluentialSayeed, M. A., Farooqi, J., Jabeen, K., Awan, S., & Mahmood, S. F. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3999-y · Cited by 76
Self-citationCandida auris Phenotypic Heterogeneity Determines Pathogenicity In Vitro
Brown, J. L., Delaney, C., Short, B., Butcher, M. C., McKloud, E., Williams, C., Kean, R., & Ramage, G. (2020) · mSphere · doi:10.1128/msphere.00371-20 · Cited by 76
“23 auris [2, 9], containing isolates capable of forming aggregates with enhanced drug 24 resistance, has meant that unravelling the pathogenic mechanisms employed by C.”
BackgroundInfluentialCandida auris: An Overview of How to Screen, Detect, Test and Control This Emerging Pathogen
Fasciana, T., Cortegiani, A., Ippolito, M., Giarratano, A., Diquattro, O., Lipari, D., Graceffa, D., & Giammanco, A. (2020) · Antibiotics · doi:10.3390/antibiotics9110778 · Cited by 84
Saris, K., Meis, J. F., & Voss, A. (2018) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000469 · Cited by 76
Self-citationSexton, D. J., Kordalewska, M., Bentz, M. L., Welsh, R. M., Perlin, D. S., & Litvintseva, A. P. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01337-18 · Cited by 77
Self-citationPlant synthetic biology for producing potent phyto-antimicrobials to combat antimicrobial resistance
Tiwari, P., Khare, T. R., Shriram, V., Bae, H., & Kumar, V. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107729 · Cited by 79
LncRNA DINOR is a virulence factor and global regulator of stress responses in Candida auris
Gao, J., Chow, E. W. L., Wang, H., Xu, X., Cai, C., Song, Y., Wang, J., & Wang, Y. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00915-x · Cited by 81
First report of sporadic cases of Candida auris in Colombia
Parra-Giraldo, C. M., Valderrama, S. L., Cortes-Fraile, G., Garzón, J. R., Ariza, B. E., Morio, F., Linares-Linares, M. Y., Ceballos-Garzón, A., de la Hoz, A., Hernandez, C., et al. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.01.034 · Cited by 74
Carolus, H., Sofras, D., Boccarella, G., Sephton-Clark, P., Biriukov, V., Cauldron, N. C., Lobo Romero, C., Vergauwen, R., Yazdani, S., Pierson, S., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01854-z · Cited by 72
Self-citationArendrup, M. C., Jørgensen, K. M., Hare, R. K., & Chowdhary, A. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02136-19 · Cited by 70
Self-citationA One Health approach to overcoming fungal disease and antifungal resistance
Woods, M., McAlister, J. A., & Geddes‐McAlister, J. (2023) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1610 · Cited by 80
Wiederhold, N. P., Najvar, L. K., Shaw, K. J., Jaramillo, R., Patterson, H., Olivo, M., Catano, G., & Patterson, T. F. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01120-19 · Cited by 71
“Given the rapid spread of this emerging infection, the high mortality rates associated with invasive disease (1), and limited treatment options in the face of antifungal resistance, new therapeutic agents and treatment strategies are needed.”
BackgroundFirst reported case of multidrug-resistant Candida auris in Canada
Schwartz, I., & Hammond, G. (2017) · Canada Communicable Disease Report · doi:10.14745/ccdr.v43i78a02 · Cited by 67
“Resistance to all three major classes of antifungals was reported in 4% of isolates (5).”
BackgroundInfluentialAnalysis of Candida auris fungemia at a single facility in Kenya
Adam, R. D., Revathi, G., Okinda, N., Fontaine, M., Shah, J., Kagotho, E., Castanheira, M., Pfaller, M. A., & Maina, D. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.06.001 · Cited by 72
Self-citationIyer, K. R., Camara, K., Daniel-Ivad, M., Trilles, R., Pimentel-Elardo, S. M., Fossen, J. L., Marchillo, K., Liu, Z., Singh, S., Muñoz, J. F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20183-3 · Cited by 72
Self-citationPathirana, R. U., Friedman, J., Norris, H. L., Salvatori, O., McCall, A. D., Kay, J., & Edgerton, M. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01872-17 · Cited by 70
“by genome architecture and single nucleotide polymorphism (SNP) variations (12, 15).”
BackgroundIguchi, S., Itakura, Y., Yoshida, A., Kamada, K., Mizushima, R., Arai, Y., Uzawa, Y., & Kikuchi, K. (2019) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2019.05.034 · Cited by 69
Understanding the mechanisms of resistance to azole antifungals in Candida species
Li, Y., Hind, C. K., Furner-Pardoe, J., Sutton, J. M., & Rahman, K. M. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf106 · Cited by 78
Vatanshenassan, M., Boekhout, T., Meis, J. F., Berman, J., Chowdhary, A., Ben-Ami, R., Sparbier, K., & Kostrzewa, M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00020 · Cited by 66
“In some hospitals in Asia C. auris is the second most common isolated species from blood cultures (Mathur et al., 2018).”
BackgroundSelf-citationRybak, J. M., Sharma, C., Doorley, L. A., Barker, K. S., Palmer, G. E., & Rogers, P. D. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01585-21 · Cited by 69
Candida auris: An emerging pathogen “incognito”?
Nett, J. E. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1007638 · Cited by 69
Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs
Romera, D., Aguilera-Correa, J. J., Gadea, I., Viñuela-Sandoval, L., García-Rodríguez, J., & Esteban, J. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001036 · Cited by 67
Magobo, R. E., Lockhart, S. R., & Govender, N. P. (2020) · Mycoses · doi:10.1111/myc.13070 · Cited by 73
Self-citationCandida auris as an Emergent Public Health Problem: A Current Update on European Outbreaks and Cases
Geremia, N., Brugnaro, P., Solinas, M. L., Scarparo, C., & Panese, S. (2023) · Healthcare · doi:10.3390/healthcare11030425 · Cited by 79
Garcia-Bustos, V., Cabañero-Navalon, M. D., Ruiz-Gaitán, A., Salavert, M., Tormo-Mas, M. Á., & Pemán, J. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.03.016 · Cited by 68
One population, multiple lifestyles: Commensalism and pathogenesis in the human mycobiome
Proctor, D. M., Drummond, R. A., Lionakis, M. S., & Segre, J. A. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.02.010 · Cited by 68
de Oliveira, H. C., Monteiro, M. C., Rossi, S. A., Pemán, J., Ruiz-Gaitán, A., Mendes-Giannini, M. J. S., Mellado, E., & Zaragoza, O. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00083 · Cited by 70
Multidrug-resistant Candida auris : an epidemiological review
Chakrabarti, A., & Singh, S. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1750368 · Cited by 66
“Nucleoside analogs ● Uracil phosphoribosyl-transferase the target of flucytosine is encoded by FUR1 gene F211I substitution of amino acids in FUR1 [2]”
BackgroundInfluentialLamoth, F., Lewis, R. E., & Kontoyiannis, D. P. (2020) · Journal of Fungi · doi:10.3390/jof7010017 · Cited by 69
“In particular, there is currently no established CBPs for emerging Candida auris, which exhibit a large variability of MIC values and a remarkable ability to rapidly induce resistance to all three antifungal drug classes [71,72].”
BackgroundMechanisms of pathogenicity for the emerging fungus Candida auris
Horton, M. V., Holt, A. M., & Nett, J. E. (2023) · PLOS Pathogens · doi:10.1371/journal.ppat.1011843 · Cited by 67
Experimental mouse models of disseminated Candida auris infection
Xin, H., Mohiuddin, F., Tran, J., Adams, A., & Eberle, K. (2019) · mSphere · doi:10.1128/msphere.00339-19 · Cited by 67
“auris infection (17, 18), which prompted us to explore if the interaction between neutrophils and C.”
BackgroundBrandão, J. C., Gangneux, J., Arıkan-Akdağlı, S., Barac, A. M., Bostănaru, A.-C., Brito, S., Bull, C. M., Çerikçioğlu, N., Chapman, B., Efstratiou, M. A., et al. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.146598 · Cited by 71
“The recently emerged detected pathogen, Candida auris, whose ecological niche is thus far unknown, is of special interest as it shows high levels of resistance to currently available antifungal drugs (Chowdhary et al., 2017; Lockhart et al., 2017).”
BackgroundRather, I. A., Sabir, J. S. M., Asseri, A. H., & Ali, S. (2022) · Journal of Fungi · doi:10.3390/jof8020204 · Cited by 71
“to have high antifungal drug resistance, with elevated MIC values to all three major antifungals (polyenes, azoles, and echinocandins) therefore narrowing the therapeutic options [5].”
BackgroundSexton, D. J., Bentz, M. L., Welsh, R. M., & Litvintseva, A. P. (2018) · Mycoses · doi:10.1111/myc.12817 · Cited by 65
Self-citationHou, X., Lee, A., Jiménez-Ortigosa, C., Kordalewska, M., Perlin, D. S., & Zhao, Y. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01811-18 · Cited by 66
“auris has become a global concern, with existing multidrug resistance to fluconazole and amphotericin B, and is characterized by a strong potential for nosocomial transmission (4, 9).”
BackgroundAllert, S., Schulz, D., Kämmer, P., Großmann, P., Wolf, T., Schäuble, S., Panagiotou, G., Brunke, S., & Hube, B. (2022) · Virulence · doi:10.1080/21505594.2022.2026037 · Cited by 66
“auris B8441, representing the South Asian clade I [11,12]) to human blood.”
BackgroundMethodInfluentialCandida auris Sternal Osteomyelitis in a Man from Kenya Visiting Australia, 2015
Heath, C. H., Dyer, J. R., Pang, S., Coombs, G. W., & Gardam, D. J. (2019) · Emerging Infectious Diseases · doi:10.3201/eid2501.181321 · Cited by 59
“auris transmission (2); he required treatment in Australia 3 years later and exhibited clinically significant disease associated with South Africa clade III C.”
BackgroundMethodInfluentialMultiple roles of ABC transporters in yeast
Kumari, S., Kumar, M., Gaur, N. A., & Prasad, R. (2021) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2021.103550 · Cited by 70
Kilburn, S., Innes, G., Quinn, M., Southwick, K., Ostrowsky, B., Greenko, J. A., Lutterloh, E., Greeley, R., Magleby, R., Chaturvedi, V., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02242-21 · Cited by 66
“auris genotypes comprise South Asia (clade I), East Asia (clade II), Africa (clade III), and South America (clade IV) (5).”
BackgroundNeonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS study
Cook, A., Ferreras-Antolin, L., Adhisivam, B., Ballot, D. E., Berkley, J. A., Bernaschi, P., Carvalheiro, C. G., Chaikittisuk, N., Chen, Y., Chibabhai, V., et al. (2023) · Medical Mycology · doi:10.1093/mmy/myad010 · Cited by 67
The Zebrafish as a Model Host for Invasive Fungal Infections
Rosowski, E. E., Knox, B. P., Archambault, L. S., Huttenlocher, A., Keller, N. P., Wheeler, R. T., & Davis, J. M. (2018) · Journal of Fungi · doi:10.3390/jof4040136 · Cited by 72
Garcia-Bustos, V., Ruiz-Saurí, A., Ruiz-Gaitán, A., Sigona-Giangreco, I. A., Cabañero-Navalon, M. D., Sabalza-Baztán, O., Salavert-Lletí, M., Tormo, M. Á., & Pemán, J. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00013-21 · Cited by 66
“Moreover, it questions the idea that each clade harbors nearly identical strains and emphasizes the importance of transcriptomic and proteomic analyses of different strains (2, 43, 44).”
BackgroundRiera, F. O., Caeiro, J. P., Angiolini, S. C., Vigezzi, C., Rodriguez, E., Icely, P. A., & Sotomayor, C. E. (2022) · Antibiotics · doi:10.3390/antibiotics11070877 · Cited by 65
Sayeed, M. A., Farooqi, J., Jabeen, K., & Mahmood, S. F. (2020) · Medical Mycology · doi:10.1093/mmy/myz112 · Cited by 59
Self-citationHeaney, H., Laing, J., Paterson, L., Walker, A. W., Gow, N. A. R., Johnson, E. M., MacCallum, D. M., & Brown, A. J. P. (2020) · Medical Mycology · doi:10.1093/mmy/myz127 · Cited by 61
Garcia-Bustos, V., Salavert, M., Ruiz-Gaitán, A. C., Cabañero-Navalon, M. D., Sigona-Giangreco, I. A., & Pemán, J. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.02.001 · Cited by 61
Trends in the molecular epidemiology and population genetics of emerging Sporothrix species
de Carvalho, J. A., Beale, M. A., Hagen, F., Fisher, M. C., Kano, R., Bonifáz, A., Toriello, C., Negroni, R., Rego, R. S. D. M., Gremião, I. D. F., et al. (2021) · Studies in Mycology · doi:10.1016/j.simyco.2021.100129 · Cited by 84
“2020), and whole-genome sequencing (Lockhart et al. 2017).”
Emergence of the novel sixth Candida auris Clade VI in Bangladesh
Khan, T., Faysal, N. I., Hossain, M. M., Mah-E-Muneer, S., Haider, A., Moon, S. B., Sen, D., Ahmed, D., Parnell, L. A., Jubair, M., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.03540-23 · Cited by 61
Bidaud, A. L., Botterel, F., Chowdhary, A., & Dannaoui, E. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01393-19 · Cited by 62
Self-citationO’Brien, B., Chaturvedi, S., & Chaturvedi, V. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02195-19 · Cited by 63
Hu, S., Zhu, F., Jiang, W., Wang, Y., Quan, Y., Zhang, G., Gu, F., & Yang, Y. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.658329 · Cited by 64
Mambro, T. D., Guerriero, I., Aurisicchio, L., Magnani, M., & Marra, E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00080 · Cited by 66
Metadata
- Authors
- Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., Berkow, E. L., Castanheira, M., Magobo, R. E., Jabeen, K., Asghar, R. J., Meis, J. F., Jackson, B., Chiller, T., & Litvintseva, A. P.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Aga Khan University (PK)
- University of Delhi (IN)
- National Health Laboratory Service (ZA)
- Universidade Federal de São Paulo (BR)
- Universidad del Zulia (VE)
- Broad Institute (US)
- JMI Laboratories (US)
- Radboud University Nijmegen (NL)
- ORCID
- Lockhart, Shawn R.
- Vallabhaneni, Snigdha
- Farooqi, Joveria
- Chowdhary, Anuradha
- Govender, Nelesh P.
- Colombo, Arnaldo Lopes
- Cuomo, Christina A.
- Desjardins, Christopher A.
- Berkow, Elizabeth L.
- Castanheira, Mariana
- Magobo, Rindidzani E.
- Jabeen, Kauser
- Asghar, Rana J.
- Meis, Jacques F.
- Jackson, Brendan
- Chiller, Tom
- Litvintseva, Anastasia P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-10-20
- Volume
- 64
- Issue
- 2
- Pages
- 134-140
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5215215
- OpenAlex
- W2536287248
- Semantic Scholar
- c8d8e54651d8fb7a7ece68270cd2630d1cd0df39
- Cited by
- 1,662
- References
- 32
- Citations by year
- 2026: 196 · 2025: 194 · 2024: 203 · 2023: 186 · 2022: 160 · 2021: 178 · 2020: 187 · 2019: 152 · 2018: 116 · 2017: 81 · 2016: 5
- FWCI
- 108.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- public-domain
- Locations
- Clinical Infectious Diseases (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- UNIFESP Institutional Repository (Universidade Federal de São Paulo) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (U19AI110818)
- United States Agency for International Development (4-338/PAK-US/HEC/2010/932)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Candida auris, multidrug resistance, antifungal resistance, clonal populations, ERG11 mutations, azole resistance, fluconazole resistance, bloodstream infection, invasive candidiasis, nosocomial infections, risk factors, transmission, whole genome sequencing, antifungal susceptibility
- MeSH terms
- Whole Genome Sequencing, Adolescent, Adult, Aged, Antifungal Agents, Candida, Candidiasis, Child, Child, Preschool, Cytochrome P-450 Enzyme System, Female, Humans, Infant, Infant, Newborn, Male, Microbial Sensitivity Tests, Middle Aged, Mutation, Phylogeny, RNA, Ribosomal, 28S, Global Health, Genome, Fungal, Drug Resistance, Multiple, Polymorphism, Single Nucleotide, DNA, Ribosomal Spacer, Drug Resistance, Fungal, Young Adult, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.